Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders

Overview of attention for article published in Frontiers in immunology, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 50,860 followers.

Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders https://t.co/cEeq8OVKhc https://t.co/iXRzI2QtPF

10 Nov 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neur…

09 Nov 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neur…

09 Nov 2022

Reply Repost Favourite

New Research: Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders: Background and objective Neuromyelitis optica spectrum disorders (NMOSD) are… https://t.co/pGEWz9

09 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.